Loading clinical trials...
Loading clinical trials...
A Pilot, Pharmacodynamic Correlate Trial of Sirolimus in Combination With Chemotherapy (Idarubicin, Cytarabine) for the Treatment of Newly Diagnosed Acute Myelogenous Leukemia
Conditions
Interventions
Sirolimus
Idarubicin
+1 more
Locations
1
United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
March 15, 2013
Primary Completion Date
December 12, 2019
Completion Date
December 12, 2019
Last Updated
April 29, 2025
NCT00352365
NCT01235572
NCT01839240
NCT01093586
NCT01872819
NCT00666588
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions